Depressive symptoms during buprenorphine treatment of opioid abusers

J Subst Abuse Treat. 1990;7(1):51-4. doi: 10.1016/0740-5472(90)90035-o.

Abstract

Among 40 opioid addicts treated as outpatients with sublingual buprenorphine (2-8 mg daily) for a month, depressive symptoms significantly decreased in the 19 who were depressed at intake to treatment.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adult
  • Buprenorphine / therapeutic use*
  • Cocaine
  • Combined Modality Therapy
  • Depressive Disorder / psychology
  • Depressive Disorder / rehabilitation*
  • Female
  • Follow-Up Studies
  • Humans
  • Male
  • Methadone / therapeutic use
  • Opioid-Related Disorders / psychology
  • Opioid-Related Disorders / rehabilitation*
  • Personality Tests
  • Substance-Related Disorders / rehabilitation

Substances

  • Buprenorphine
  • Cocaine
  • Methadone